Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases
-
By
-
Xiaoge An
-
Tingting Wu
-
Rong Gou
-
Yudong Fang
-
June 18, 2026
-
Clinical Scorecard: Progress in CAR-T Cell Therapy for Addressing Age-Related Disorders
At a Glance
| Category | Detail |
|---|
| Condition | Age-related diseases |
| Key Mechanisms | Cellular senescence and senescence-associated secretory phenotype (SASP) |
| Target Population | Aging population with age-related diseases such as cancer, Alzheimer's disease, and cardiovascular disease |
| Care Setting | Clinical and experimental settings |
Key Highlights
- Cellular senescence drives aging and age-related diseases.
- CAR-T cell therapy shows potential in targeting age-related diseases.
- Current challenges include immune-senescence and treatment safety.
- Research focuses on engineered immune cells and combination therapy.
- CAR-T therapy has demonstrated efficacy in hematological malignancies.
Guideline-Based Recommendations
Diagnosis
- Identify cellular senescence markers in patients.
Management
- Consider CAR-T cell therapy for eligible patients with age-related diseases.
Monitoring & Follow-up
- Monitor for immune-senescence and treatment-related adverse effects.
Risks
- Potential side effects associated with CAR-T therapy.
Patient & Prescribing Data
Patients with age-related diseases, particularly those with cancer and neurodegenerative conditions.
CAR-T therapy may provide a targeted approach to eliminate senescent cells.
Clinical Best Practices
- Integrate CAR-T therapy into treatment plans for age-related diseases.
- Evaluate the safety and efficacy of CAR-T therapy in clinical trials.
- Address immune-senescence in treatment strategies.
Related Resources & Content
